Medical Devices Brazil

Brazil Hematology Analyzers Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Brazil Hematology Analyzers Market Industry Trends and Forecast to 2034: Segmented by (Product, Type, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Brazil · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $139.0 Mn Placeholder estimate
Estimate 2025 $148.3 Mn 2.7% of the global market
Projected 2034 $265.9 Mn 79.3% Adds $117.6 Mn over 9 forecast years
CAGR 2025–2034 6.7% Faster than 8% of 173 Medical Devices markets here
Key players 5
  • Brazil is 2.67% of the global market.
  • In Latin America, the largest is Brazil (this report) at $148.3 Mn.
  • Fastest growing: Brazil (this report) at 6.7% a year.
  • Brazil ranks 1st of 3 by size in Latin America.

Market size projection

Brazil

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$117.6 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Hematology Analyzers Market market size by year, Brazil
YearMarket sizeChange that yearSince 2025
2024 (estimate) $139.0 Mn — —
2025 (base) $148.3 Mn +$9.3 Mn —
2026 (forecast) $158.3 Mn +$9.9 Mn +6.7%
2027 (forecast) $168.9 Mn +$10.6 Mn +13.8%
2028 (forecast) $180.2 Mn +$11.3 Mn +21.5%
2029 (forecast) $192.3 Mn +$12.1 Mn +29.6%
2030 (forecast) $205.2 Mn +$12.9 Mn +38.3%
2031 (forecast) $218.9 Mn +$13.7 Mn +47.6%
2032 (forecast) $233.6 Mn +$14.7 Mn +57.5%
2033 (forecast) $249.2 Mn +$15.6 Mn +68%
2034 (forecast) $265.9 Mn +$16.7 Mn +79.3%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Brazil Hematology Analyzers Market Analysis at a glance
Market size, 2025$148.3 Mn placeholder estimate
Forecast, 2034$265.9 Mn placeholder estimate
Growth (CAGR), 2025–20346.7% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, type and end user (see all)
Key playersSysmex Corporation, Beckman Coulter (Danaher), Abbott Laboratories, Siemens Healthineers, Mindray Medical International Limited (see all)
Regulator in BrazilANVISASource: ANVISA. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Brazil Hematology Analyzers Market Analysis Executive Summary

Hematology analysers count and check blood cells to find anaemia, infections and blood cancers.

Key segments of the hematology Analyzers market include product (Analyzers, Reagents and Services) and type (3-Part Differential, 5-Part Differential and 6-Part and Above).

Bar chart: Brazil Hematology Analyzers market size, 2024–2034, placeholder estimates. $139.0 Mn in 2024, $148.3 Mn in 2025 and $265.9 Mn in 2034, 6.7% CAGR.
Brazil Hematology Analyzers market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Brazil Hematology Analyzers Market Dynamics

Market Growth Drivers

Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the hematology Analyzers market.

Opportunity

Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the hematology Analyzers market room to grow, especially in emerging markets.

Market Restraints

Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the hematology Analyzers market.

Competitive Landscape for Hematology Analyzers Market in Brazil

The hematology Analyzers market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Hematology Analyzers Market in Brazil

Hematology Analyzers in Brazil: rules and payment

Medical devices are notified to or registered with ANVISA, the National Health Surveillance Agency, depending on their risk class.⁠[1] The Unified Health System (SUS) gives free public care to everyone, and CONITEC advises which medicines and technologies it adds.⁠[2]

[1] ANVISA. Checked 14 Nov 2026.

[2] CONITEC. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how hematology Analyzers products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Brazil.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Hematology Analyzers right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Hematology Analyzers in context

Brazil compared

  • Health spending per person: 1,010 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 4 countries we cover in Latin America.[1]
  • Doctors: 2.36 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 2nd highest of the 4 countries we cover in Latin America.[2]
  • People aged 65 and over: 11.5% of people (2025). World: 10.4% of people (2025). Highest of the 4 countries we cover in Latin America.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Hematology Analyzers market in Brazil?
Placeholder estimate: about $148.3 Mn in 2025, rising to about $265.9 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Hematology Analyzers market in Brazil growing?
Placeholder estimate: about 6.7% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Hematology Analyzers market report cover?
The report splits the market by product (Analyzers, Reagents, Services), type (3-Part Differential, 5-Part Differential, 6-Part and Above) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Hematology Analyzers market?
Key players include Sysmex Corporation, Beckman Coulter (Danaher), Abbott Laboratories, Siemens Healthineers and Mindray Medical International Limited.
What is driving the Hematology Analyzers market?
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the hematology Analyzers market.
Who regulates Hematology Analyzers in Brazil?
Medical devices are notified to or registered with ANVISA, the National Health Surveillance Agency, depending on their risk class. Source: ANVISA. Checked 14 Nov 2026.
How is healthcare paid for in Brazil?
The Unified Health System (SUS) gives free public care to everyone, and CONITEC advises which medicines and technologies it adds. Source: CONITEC. Checked 14 Nov 2026.
How much research is published on Hematology Analyzers?
PubMed lists 230 papers on Hematology Analyzers added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Brazil

See all

Related on diagnostics and lab testing and anemia

See the topic